Background: Systemic sclerosis (SS) is a collagen vascular disease of unknown etiology that is characterized by connective tissue abnormalities. This study aimed to evaluate the extra-pulmonary manifestations of SS on chest high resolution computed tomography (HRCT).
INTRODUCTION
Systemic sclerosis is a chronic multisystem autoimmune disease that produces inflammation and fibrosis of the skin and several internal organs including the lungs, esophagus, musculoskeletal system, heart, and kidneys (1, 2) . The exact etiology and pathogenesis are unknown. Depending on the extent of cutaneous involvement, the disease is classified into two types including diffuse cutaneous and localized cutaneous forms (1) . The disease is associated with high morbidity and mortality, and ILD is the main cause of morbidity and TANAFFOS mortality in patients with SS (2) . Internal organ involvement is also an important determinant of mortality in these patients. The disease usually involves the young and middle aged women (3) . The lungs are involved in nearly 90% of SS patients at autopsy and 40% of SS patients have abnormal pulmonary function test (4) . Only 25% of SS patients have respiratory symptoms or radiographic manifestation of pulmonary involvement. Also, ILD, mainly in the form of fibrosis and PAH are the two most common complications and the leading causes of morbidity and mortality in patients with SS (2) . In the recent years, evidence has been accumulating that immunosuppressive treatment in an early stage of the disease can improve survival, which mandates early, accurate diagnosis and complete evaluation of multiple organ involvement in these patients (1, 2) . Patients with SS are routinely investigated with chest HRCT for detecting lung involvement and evaluating the severity of ILD (1, 2, 5) . HRCT is more sensitive than chest radiograph to diagnose multiple intra-thoracic but extra pulmonary involvements in these patients. The extra pulmonary involvement can increase the complications and increase the mortality and morbidity of the disease. The aim of this study was to discuss the extra pulmonary manifestations of SS patients on chest HRCT and to describe the significance of these imaging findings.
MATERIALS AND METHODS
This was a descriptive retrospective study, which was The HRCT findings of extra-pulmonary manifestations of SS were investigated in the patients.
All registered data were transferred to SPSS 15, and analyzed using Mann-Whitney and Kruskal-Wallis tests.
The results were regarded as significant when P-value was less than 0.05.
We used the following imaging criteria in our study:
• Esophageal dilatation:
-Coronal diameter of esophagus more than 9 mm in the infra-aortic portion and/or presence of air-fluid level in the esophagus.
• Pleural disease: pleural thickening or pleural effusion.
• Pericardial disease: Pericardial thickening or pericardial effusion.
• Pulmonary arterial enlargement: diameter of the main pulmonary artery at the level of bifurcation greater than 29mm.
-All patients underwent echocardiography to be evaluated for PAH.
• Mediastinal lymphadenopathy: Presence of lymph nodes greater than 9mm in short axis in contrastenhanced or non-contrast chest HRCT studies.
• Pulmonary fibrosis:
-Presence of intralobular septal thickening -Presence of obvious fibrotic bands in the mid or lower zones of the lungs. Pleural involvement was detected on HRCT in 12 patients (40%). Pleural thickening was more common and was seen in eight patients, and pleural effusion was detected only in four cases.
RESULTS

Forty
Pericardial abnormalities were seen in 12 patients (40%). Pericardial effusion was seen in seven patients, and diffuse pericardial thickening in five cases.
Chest HRCT demonstrated pulmonary artery dilatation in eight patients (20%). Main pulmonary artery enlargement was detected if the transverse diameter of the main pulmonary artery exceeded 3 cm. There was a positive correlation between the presence of esophageal dilatation and the incidence of pulmonary artery dilatation, and pulmonary fibrosis in our series (P<0.05).
Among the eight patients that had imaging evidence of pulmonary artery dilatation, seven (87.5%) showed PAH in echocardiography. There were also three (7.5%) patients with echocardiographic PAH that did not have imaging manifestations of pulmonary dilatation. As our study's aim was to evaluate the HRCT findings in SS patients, these three patients were not considered positive for pulmonary artery involvement based on imaging.
Mediastinal Table 1 shows various pulmonary and extra pulmonary findings on chest HRCT scans of patients with SS. 
Esophageal involvement
Esophagus is the first organ in the gastrointestinal tract that is affected in SS, followed by the anorectal region.
Esophageal dysmotility is a common manifestation in patients with SS and is reported in 75% of patients (1, 9).
Esophageal dysmotility may cause esophageal dilatation 
Pericardial disease
The radiographic features of pericarditis with associated effusion were first described by Steinberg and Abu-Shakra and associates reported a patient with pericardial effusion, massive pleural effusion, and renal failure (19) . Pericardial abnormalities were presented in 30% of patients in our study. 
Pulmonary arterial enlargement
Interstitial lung disease andPAH are the most common cardiopulmonary manifestations of SS (1, 3, 20) . PAH is typically associated with severe lung disease in these patients and may be seen as an isolated finding.
Pulmonary arterial hypertension is one of the common extra pulmonary manifestations of SS with an incidence of 10 to 8o% (1, 20) ; 33% of patients with SS show evidence of PAH at angiography (1, 3) . On chest radiograph, it is characterized by an enlarged main pulmonary artery, attenuation of the smaller vessels and cardiomegaly (3).
Computed tomography is an accurate method for measuring the size of main pulmonary artery (21) . 
